Antiplatelet therapy and incident cognitive impairment or dementia-a systematic review and meta-analysis of randomised clinical trials.


Journal

Age and ageing
ISSN: 1468-2834
Titre abrégé: Age Ageing
Pays: England
ID NLM: 0375655

Informations de publication

Date de publication:
02 10 2023
Historique:
received: 05 05 2023
medline: 30 10 2023
pubmed: 29 10 2023
entrez: 28 10 2023
Statut: ppublish

Résumé

The benefit of antiplatelet therapy in preventing cognitive impairment or dementia is uncertain. We investigated the association between antiplatelet therapy and incident cognitive impairment or dementia in randomised clinical trials. We searched PubMed, EMBASE and CENTRAL for randomised clinical trials published from database inception through 1 February 2023. Trials that evaluated the association of antiplatelet therapy with incident cognitive impairment or dementia were included. For single-agent antiplatelet, the control group was placebo. For dual agent antiplatelet therapy, the control group was single-agent monotherapy. A random-effects meta-analysis model was used to report pooled treatment effects and 95% confidence intervals (CIs). The primary outcome was incident cognitive impairment or dementia. Secondary outcomes included change in cognitive test scores. A total of 11 randomised clinical trials were included (109,860 participants). All reported the incidence of cognitive impairment or dementia on follow-up. The mean (SD) age of trial participants was 66.2 (7.9) years. Antiplatelet therapy was not significantly associated with a reduced risk of cognitive impairment or dementia (11 trials; 109,860 participants) (3.49% versus 4.18% of patients over a mean trial follow-up of 5.8 years; odds ratio [OR], 0.94 [95% CI, 0.88-1.00]; absolute risk reduction, 0.2% [95% CI, -0.4% to 0.009%]; I2 = 0.0%). Antiplatelet therapy was not significantly associated with mean change in cognitive test scores. In this meta-analysis, antiplatelet therapy was not significantly associated with a lower risk of incident cognitive impairment or dementia, but the CIs around this outcome do not exclude a modest preventative effect.

Identifiants

pubmed: 37897809
pii: 7330500
doi: 10.1093/ageing/afad197
pmc: PMC10612993
pii:
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Meta-Analysis Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

J Stroke Cerebrovasc Dis. 2015 Oct;24(10):2236-44
pubmed: 26272868
Eur J Neurol. 2005 Oct;12 Suppl 3:11-6
pubmed: 16144532
BMJ. 2007 May 12;334(7601):987
pubmed: 17468120
Lancet Neurol. 2014 Dec;13(12):1177-85
pubmed: 25453457
Ann Neurol. 2019 Jan;85(1):114-124
pubmed: 30421454
Front Aging Neurosci. 2022 Mar 31;14:788407
pubmed: 35431899
Alzheimers Dement. 2009 Nov;5(6):492-7
pubmed: 19647495
JAMA Neurol. 2023 Jul 1;80(7):682-692
pubmed: 37222252
Eur Heart J. 2022 Jun 1;43(21):2010-2019
pubmed: 35393614
N Engl J Med. 2009 May 14;360(20):2066-78
pubmed: 19336502
Cochrane Database Syst Rev. 2020 Apr 30;4:CD011459
pubmed: 32352165
Neuropsychol Rev. 2018 Mar;28(1):1-15
pubmed: 28856507
Diabetes Care. 2020 Feb;43(2):314-320
pubmed: 31801787
BMJ. 2011 Aug 30;343:d4829
pubmed: 21878462
Cochrane Database Syst Rev. 2022 Jul 14;7:CD012269
pubmed: 35833913
J Alzheimers Dis. 2020;73(3):1157-1166
pubmed: 31884487
JAMA Neurol. 2023 Mar 1;80(3):251-259
pubmed: 36716007
N Engl J Med. 2019 Oct 3;381(14):1309-1320
pubmed: 31475798
Cochrane Database Syst Rev. 2014 Mar 26;(3):CD000029
pubmed: 24668137
Eur Neurol. 2006;55(2):61-9
pubmed: 16534208
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Contemp Clin Trials. 2023 Jul;130:107231
pubmed: 37196887
JAMA. 2022 Apr 26;327(16):1577-1584
pubmed: 35471505
Alzheimers Dement (Amst). 2021 Mar 31;13(1):e12161
pubmed: 33816754
Alzheimers Dement. 2007 Jul;3(3):186-91
pubmed: 19595937
Ann Intern Med. 2016 Jun 21;164(12):826-35
pubmed: 27064261
Neurology. 2020 Jul 21;95(3):e320-e331
pubmed: 32213642
Age Ageing. 2020 Feb 27;49(2):154-160
pubmed: 31830268
Int J Stroke. 2020 Jan;15(1):9-17
pubmed: 31237833
Lancet. 2018 Sep 22;392(10152):1036-1046
pubmed: 30158069
Stroke. 2021 Oct;52(10):3088-3096
pubmed: 34192893
BMJ. 2010 Mar 30;340:c117
pubmed: 20354011
BMJ. 2008 Sep 01;337:a1198
pubmed: 18762476
N Engl J Med. 2015 May 7;372(19):1791-800
pubmed: 25773268
Front Aging Neurosci. 2021 Feb 04;12:578071
pubmed: 33613260
J Am Med Dir Assoc. 2022 Dec;23(12):1986-1989.e1
pubmed: 35561758

Auteurs

Kevin Kitt (K)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.

Robert Murphy (R)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.

Aoibhin Clarke (A)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.

Catriona Reddin (C)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.
Wellcome Trust - HRB, Irish Clinical Academic Training, Galway, Ireland.

John Ferguson (J)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.

Jackie Bosch (J)

Population Health Research Institute, Hamilton, McMaster University, Ontario, Canda.

William Whiteley (W)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Michelle Canavan (M)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.

Conor Judge (C)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.

Martin O'Donnell (M)

HRB-Clinical Research Facility, University of Galway, Galway, Ireland.
Population Health Research Institute, Hamilton, McMaster University, Ontario, Canda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH